Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of August 2020
Date Filed: August 31, 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves as a preliminary final report and is incorporated by reference into Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417).
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the full content of the "Preliminary Final Report" referenced in Item 99.1, as the financial details are not included in this Form 6-K cover page.
- Confirm the status of the Registration Statements on Form S-8 and Form F-3 referenced for incorporation.
- Review the company's Form 20-F filings for the most recent audited financial statements, as this 6-K does not contain them.